Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 18;3(1):154-161.
doi: 10.1089/pmr.2021.0066. eCollection 2022.

The Short Health Scale: A Valid and Reliable Quality-of-Life Scale for Mainland Chinese Patients with Inflammatory Bowel Disease

Jiang-Tao Hou  1 , Bin Peng  2 , Shi-Jing Zhang  3 , Yong-Xin Luo  3 , Yi-Ming Chen  3 , Jia-Zhong Cai  4   5 , Yi Wen  1 , Hong Mi  1 , Jian-Feng Luo  3 , Xiao-Mei Zheng  2 , Si-Min Pan  2 , Shi-Ying Liu  3 , Xin-Lin Chen  3 , Bin Chen  1
Affiliations

The Short Health Scale: A Valid and Reliable Quality-of-Life Scale for Mainland Chinese Patients with Inflammatory Bowel Disease

Jiang-Tao Hou et al. Palliat Med Rep. .

Abstract

Background: The aim of our study was to translate and validate the mainland Chinese version of the short health scale (SHS), a disease-specific quality-of-life (QoL) scale for patients with inflammatory bowel disease (IBD).

Methods: The SHS was translated and validated according to the standard process: a translation and back-translation procedure and a reliability and validation study. Patients with IBD were enrolled, and their QoL was assessed using the SHS, the short inflammatory bowel disease questionnaire (SIBDQ), and the Bristol stool form scale. Reliability (internal consistency reliability, split-half reliability, and test-retest reliability) and validity analyses were performed to evaluate the psychometric characteristics of the SHS. The impacts of different severity of major symptoms on QoL were analyzed by comparing the scores of SHS.

Results: A total of 112 patients with IBD (69 with ulcerative colitis and 43 with Crohn's disease) completed the mainland Chinese version of the SHS, and 34 patients completed the SHS a second time within one to two weeks. Cronbach's alpha value of the SHS was 0.90, and its split-half coefficient was 0.83. Intraclass correlation coefficients of the four items ranged from 0.52 to 0.72. All four items of the SHS were significantly associated with the corresponding domains of the SIBDQ, with correlation coefficients ranging from -0.52 to -0.69 (p < 0.001). The results of confirmatory factor analysis indicated a good fit of the one-factor model, with comparative fit index (CFI) = 0.878, normed fit index (NFI) = 0.874, incremental fit index (IFI) = 0.880, and goodness of fit index (GFI) = 0.842. The patients with severe symptoms had higher scores in the SHS than those with no or mild symptoms.

Conclusions: The SHS was simple and quick to be used. The SHS had good validity and reliability and was suitable for evaluating the QoL of patients with IBD in mainland China.

Keywords: inflammatory bowel disease; quality of life; short health scale; translation; validation.

PubMed Disclaimer

Conflict of interest statement

No competing financial interests exist.

Figures

FIG. 1.
FIG. 1.
The CFA structure diagram of the SHS. (The number represented the standardized regression coefficient between a particular item and the SHS). CFA, confirmatory factor analysis; SHS, short health scale.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Baumgart DC and Sandborn WJ: Inflammatory bowel disease: Clinical aspects and established and evolving therapies. Lancet 2007;369:1641–1657. - PubMed
    1. Burisch J and Munkholm P: The epidemiology of inflammatory bowel disease. Scand J Gastroenterol 2015;50:942–951. - PubMed
    1. Ng SC, Shi HY, Hamidi N, et al. : Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet 2018;390:2769–2778. - PubMed
    1. Kaplan GG: The global burden of IBD: From 2015 to 2025. Nat Rev Gastroenterol Hepatol 2015;12:720–727. - PubMed
    1. IsHak WW, Pan D, Steiner AJ, et al. : Patient-reported outcomes of quality of life, functioning, and GI/psychiatric symptom severity in patients with inflammatory bowel disease (IBD). Inflamm Bowel Dis 2017;23:798–803. - PubMed

LinkOut - more resources